The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study

Maral Ouzounian; Ansar Hassan; Jafna L. Cox; David E. Johnstone; Jonathan Howlett

doi:10.1016/j.cardfail.2006.11.016

The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study

Maral Ouzounian, Ansar Hassan, Jafna L. Cox, David E. Johnstone, Jonathan Howlett

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	165-169
Number of pages	5
Journal	Journal of Cardiac Failure
Volume	13
Issue number	3
DOIs	https://doi.org/10.1016/j.cardfail.2006.11.016
Publication status	Published - Apr 2007

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2006.11.016

Cite this

@article{73e7a3547d974e758e44525a21c26a97,

title = "The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study",

author = "Maral Ouzounian and Ansar Hassan and Cox, {Jafna L.} and Johnstone, {David E.} and Jonathan Howlett",

note = "Funding Information: Dr. Cox receives salary support from a Canadian Institutes of Health Research/Regional Partnership Program Investigator Award and through a Clinical Research Scholarship from the Faculty of Medicine, Dalhousie University. The QE II Heart Function Clinic was supported through an unrestricted grant from AstraZeneca Canada Inc. The ICONS study was supported through a nondirected educational grant from Merck Frosst Canada Inc., and through in-kind support from the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada, and the Nova Scotia Department of Health. Since January 2003, it has been entirely funded through the Nova Scotia Department of Health. ",

year = "2007",

month = apr,

doi = "10.1016/j.cardfail.2006.11.016",

language = "English",

volume = "13",

pages = "165--169",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "3",

}

TY - JOUR

T1 - The Effect of Spironolactone Use on Heart Failure Mortality

T2 - A Population-Based Study

AU - Ouzounian, Maral

AU - Hassan, Ansar

AU - Cox, Jafna L.

AU - Johnstone, David E.

AU - Howlett, Jonathan

N1 - Funding Information: Dr. Cox receives salary support from a Canadian Institutes of Health Research/Regional Partnership Program Investigator Award and through a Clinical Research Scholarship from the Faculty of Medicine, Dalhousie University. The QE II Heart Function Clinic was supported through an unrestricted grant from AstraZeneca Canada Inc. The ICONS study was supported through a nondirected educational grant from Merck Frosst Canada Inc., and through in-kind support from the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada, and the Nova Scotia Department of Health. Since January 2003, it has been entirely funded through the Nova Scotia Department of Health.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=34247173498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247173498&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2006.11.016

DO - 10.1016/j.cardfail.2006.11.016

M3 - Article

C2 - 17448412

AN - SCOPUS:34247173498

SN - 1071-9164

VL - 13

SP - 165

EP - 169

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 3

ER -

The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this